SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes.
Joshua Sterling WellsChao WangKevin DolginReem KayyaliPublished in: Patient preference and adherence (2023)
Higher levels of MA, as determined by SPUR, were significantly associated with a lower risk of general admissions and early readmissions among patients living with Type 2 Diabetes.